Cangene Corporation

Cangene Corporation

Cangene Corporation company makes plasma products known as hyperimmunes, which are antibody preparations and recombinant biopharmaceuticals made by introducing a gene in a host organism. Cangene's drugs are used to treat plasma-derived disorders, including the blood clotting disorder thrombocytopenic purpura and hemolytic disease of the newborn, which occurs when a fetus' blood type is incompatible with its mother's. Cangene has several approved products and is developing others, mainly in the areas of infectious disease and biodefense. Generic giant Apotex owns more than 80% of Cangene.

Contact Details

Office Address

Cangene Corporation
155 Innovation Drive
Winnipeg, MB, Canada R3T5Y3
Phone: (204) 275-4200
Fax: (204) 269-7003

Executives

Chairman

Jacob M. (Jack) Kay

President, CEO, and Director

John Langstaff

Business Reviews for Cangene Corporation

Related Companies